切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2019, Vol. 08 ›› Issue (04) : 325 -328. doi: 10.3877/cma.j.issn.2095-3224.2019.04.001

所属专题: 指南与规范 文献 指南共识

指南与共识

中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)
中国医师协会结直肠肿瘤专业委员会内科专委会   
  • 收稿日期:2019-07-22 出版日期:2019-08-25

Guidelines for county physicians in diagnosis and treatment of stage Ⅱ and Ⅲ colorectal cancer in China-Internal Medicine Section (2019 edition)

Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association   

  • Received:2019-07-22 Published:2019-08-25
引用本文:

中国医师协会结直肠肿瘤专业委员会内科专委会. 中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)[J]. 中华结直肠疾病电子杂志, 2019, 08(04): 325-328.

Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association. Guidelines for county physicians in diagnosis and treatment of stage Ⅱ and Ⅲ colorectal cancer in China-Internal Medicine Section (2019 edition)[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2019, 08(04): 325-328.

国家癌症中心2019年发布的数据显示,我国结直肠癌的发病率及死亡率均呈上升趋势,主要与我国结直肠癌基本诊疗规范落实欠缺,整体诊治水平偏低有关。特别在基层级医院,由于各种资源配置相对落后,无法完全按照国际诊疗指南进行诊治,医疗水平参差不齐。鉴于县域级医院是多数结直肠癌患者的首次就诊单位,需要服务的人群基数大,制定适合于县域级医院的结直肠癌诊疗指南,提高基层医疗服务质量尤为重要。为此,中国医师协会结直肠肿瘤专业委员会内科治疗专委会起草、讨论并最终发布2019中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南内科部分,以规范Ⅱ、Ⅲ期结直肠癌的内科治疗。

According to the data released by the National Cancer Center in 2019, the morbidity and mortality of colorectal cancer in China are on the rise. This mainly related to the lack of basic medical treatment standards, and the overall level of diagnosis and treatment is still low. Especially in county-level hospitals, due to the relatively backward allocation of various resources, it is impossible to completely follow the international treatment guidelines, and the medical level is uneven. Since county-level hospitals are the first unit of treatment for most patients with colorectal cancer, and the number of people who need services is large, it is especially important to develop guidelines for colorectal cancer diagnosis and treatment suitable for county-level hospitals. To this end, Professional Committee of Internal Medicine, Colorectal Cancer Committee of Chinese Medical Doctor Association drafted, discussed, and finally released Guidelines Internal Medicine Section for county physicians in diagnosis and treatment of stageⅡ and Ⅲ colorectal cancer in China, to standardize stage Ⅱ and Ⅲ colorectal cancer medical treatment.

表1 Ⅱ期结肠癌辅助化疗推荐
表2 Ⅲ期结肠癌辅助化疗推荐
表3 直肠癌术后辅助化疗推荐
中国Ⅱ、Ⅲ期结直肠癌县域医师诊疗指南-内科部分(2019版草案)专家名单(按姓氏拼音排序)
[1]
Sargent DJ, Marsoni S, Monges G, et al. Defective mismatch repair as a predictive marker for lack of efficacy of fluorouracil based adjuvant therapy in colon cancer [J]. J Clin Oncol, 2010, 28(20): 3219-3226.
[2]
Iveson T, Sobrero AF, Yoshino T, et al. Prospective pooled analysis of four randomized trials investigating duration of adjuvant (adj) oxaliplatin-based therapy (3 vs 6 months {m}) for patients (pts) with high-risk stageⅡ colorectal cancer (CC) [J].J Clin Oncol, 2019, 37(15_suppl): pp 3501.
[3]
Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stageⅢ colon cancer [J]. N Engl J Med, 2018, 378(13): 1177-1188.
[4]
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer [J]. N Engl J Med, 2006, 355(11): 1114-1123.
[5]
Glynne-Jones R, Wyrwicz L, Tiret E, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].Ann Oncol, 2017, 28(suppl_4): iv22-iv40.
[1] 康夏, 田浩, 钱进, 高源, 缪洪明, 齐晓伟. 骨织素抑制破骨细胞分化改善肿瘤骨转移中骨溶解的机制研究[J]. 中华乳腺病杂志(电子版), 2023, 17(06): 329-339.
[2] 中华医学会骨科学分会关节外科学组, 广东省医学会骨质疏松和骨矿盐疾病分会, 广东省佛山市顺德区第三人民医院. 中国髋部脆性骨折术后抗骨质疏松药物临床干预指南(2023年版)[J]. 中华关节外科杂志(电子版), 2023, 17(06): 751-764.
[3] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[4] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[5] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[6] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[7] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[8] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[9] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[10] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[11] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[12] 黄怡诚, 陆晨, 孙司正, 喻春钊. 肝特异性转录因子FOXA2在人结直肠癌肝转移阶梯模型中的表达变化及其意义[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 396-403.
[13] 刘祺, 张凯, 李建男, 刘铜军. 结直肠癌肝转移生物治疗的现状及进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 415-419.
[14] 吴寅, 陈智琴, 高勇, 权明. Her-2阳性结直肠癌的诊治进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 420-425.
[15] 范博洋, 王宁, 张骞, 王贵玉. 结直肠癌转移调控的环状RNA分子机制研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(05): 426-430.
阅读次数
全文


摘要